Board of Directors

Ulf Wiinberg

Chairman of the board since 2016

Ulf Wiinberg is an experienced healthcare industry professional who has served the boards of several healthcare industry associations. At Wyeth, he has been both President of the global consumer health care business and President for the European pharma business, and he has also held the position as CEO of H Lundbeck A/S, a pharmaceutical company specialized in psychiatric and neurological disorders, for several years. Ulf is a non-executive Board member at Alfa Laval, Nestle Health and Science, and at the Belgian pharmaceutical company UCB. He is also chairman of Avillion. Born in 1958.

Independent of Hansa Medical and its senior management. Independent of major shareholders of Hansa Medical.

Shareholding: 75,000

Birgit Stattin Norinder

Member of the board since 2012

Birgit has extensive experience from international pharmaceutical and biotechnology companies in Sweden, the USA and the United Kingdom. She has managed several research and development departments, resulting in a number of novel and approved pharmaceuticals. Amongst many things she has served as CEO and Chairman at Prolifix Ltd., Senior VP Worldwide Product Development, Pharmacia & Upjohn and Dir. Int. Reg. Affairs Division, Glaxo Group Research Ltd. Birgit has also held several board and chairman positions of U.K., Swedish and Norwegian biotechnology companies. Birgit is also director of the board at Jettesta AB, Nicox S.A. and AddLife AB. Chairman of the Board of Hansa Medical 2014-2016. Born 1948.

Birgit is Chairman of Hansa Medical´s Remuneration Committee, and member of the Audit Committee and  Scientific Committee

Independent of Hansa Medical and its senior management. Independent of major shareholders of Hansa Medical.

Shareholding: 29,205

Dr. Stina Gestrelius

Member of the board since 2007

Stina has 30 years of experience in the pharmaceutical and biotech industries. Entrepreneur and previously Head of Research at Biora AB and Deputy CEO of Medicon Valley Alliance. She is currently member of the board in BioActive Polymers in Lund AB and Hansa Medical AB (publ.) and has held several board positions of Scandinavian biotechnology companies including Biogaia AB (publ.), Clavis Pharma ASA (publ.) and Lipopeptide AB. Born 1949.

Stina is member of the Hansa Medical Scientific Committee and of the Remuneration Committee

Independent of Hansa Medical and its senior management. Independent of major shareholders of Hansa Medical.

Shareholding: 5,833

Hans Schikan

Member of the board since 2015

Hans has more than 25 years' international (bio)pharma company experience. He is currently Chairman of the Board of Directors of Asceneuron (Switzerland), Complix (Belgium) and InteRNA Technologies (The Netherlands) and member of the Board of Directors of Sobi and Wilson Therapeutics (Sweden). He is also Member of the Core Team of the Dutch Top Sector Life Sciences & Health and adviser to several biotech companies. His past experience includes inter alia CEO of Prosensa (The Netherlands). Hans holds a Pharm.D. degree from the University of Utrecht, the Netherlands. Born 1958.

Hans is member of the Hansa Medical Scientific Committee.

Independent of Hansa Medical and its senior management. Independent of major shareholders of Hansa Medical.

Shareholding: 10,000

Per-Olof Wallström

Member of the board since 2011

Per-Olof has extensive experience from various positions in the international pharmaceutical and biotechnology industry, including Senior Management positions at Merck, Astra, Pharmacia and Bristol-Myers Squibb. In addition, he has served as CEO of Q-Med AB, Melacure Therapeutics AB and Karo Bio AB. Per-Olof is also director of the boards at Camurus AB (Chairman), MB Eriksson Bygg och Fastighet AB (Chairman) and Arosia Communication AB and Patients Pending Ltd. (Chairman).  Born 1949.

Per-Olof is member of the Hansa Medical Audit committee and of the Remuneration Committee

Independent of Hansa Medical and its senior management. Independent of major shareholders of Hansa Medical.

Shareholding: 23,000

Angelica Loskog

Member of the board since 2016

Angelica Loskog, is Doctor of Philosophy (Faculty of Medicine) and adjunct professor at the Department of Immunology, Genetics and Pathology at Uppsala University. She is scientific advisor to Nxt2b, CEO of Lokon Pharma AB, and Chairman of Vivolux AB as well as Repos Pharma AB. Born in 1973.

Independent of Hansa Medical and its senior management.

Shareholding: -